Biofrontera (0DOL) Income Statement
Biofrontera Income Statement
Last quarter (Q4 2023), Biofrontera's total revenue was $7.45M, an increase of 28.47% from the same quarter last year. In Q4, Biofrontera's net income was $5.92M. See Biofrontera’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 13.19M | $ 12.18M | $ 32.25M | $ 25.74M | $ 28.79M | |
| $ 10.91M | $ 10.12M | $ 25.37M | $ 20.98M | $ 24.87M | |
| $ 11.93M | $ 11.70M | $ 20.59M | $ 19.39M | $ 60.21M | |
| Depreciation and Amortization | $ 648.00K | $ 839.00K | $ 791.00K | $ 746.00K | $ 3.29M |
| $ -560.00K | $ -301.00K | $ 5.57M | $ 2.34M | $ -12.59M | |
| $ -1.02M | $ -1.59M | $ 4.78M | $ 1.59M | $ -35.34M | |
| $ -197.00K | $ 436.00K | $ -6.91M | $ -44.80M | $ 71.02M | |
| $ -1.22M | $ -1.15M | $ -2.13M | $ -43.21M | $ 35.68M | |
| $ -3.96M | $ -4.35M | $ -369.00K | $ -44.17M | $ 37.75M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.65 | $ -0.72 | $ -0.01 | $ -0.77 | $ 0.66 |
| Diluted EPS | $ -0.65 | $ -0.72 | $ -0.01 | $ -0.77 | $ 0.65 |
| Weighted Average Shares Outstanding | 6.08M | 6.08M | 63.81M | 57.47M | 57.90M |
| Weighted Average Shares Outstanding (Diluted) | 6.08M | 6.08M | 63.81M | 57.47M | 59.29M |
Currency in EUR